|
1
|
Parkin DM and Bray F: The burden of
HPV-related cancers. Vaccine. 24(Suppl 3): Chapter 2. S3/11–25.
2006. View Article : Google Scholar
|
|
2
|
Woodman CB, Collins SI and Young LS: The
natural history of cervical HPV infection: unresolved issues. Nat
Rev Cancer. 7:11–22. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Estimating the world cancer burden: Globocan 2000. Int J Cancer.
94:153–156. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Uren A, Fallen S, Yuan H, Usubutun A,
Kucukali T, Schlegel R, et al: Activation of the canonical Wnt
pathway during genital keratinocyte transformation: a model for
cervical cancer progression. Cancer Res. 65:6199–6206. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Perez-Plasencia C, Duenas-Gonzalez A and
Alatorre-Tavera B: Second hit in cervical carcinogenesis process:
involvement of wnt/beta catenin pathway. Int Arch Med. 1:102008.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
MacDonald BT, Tamai K and He X:
Wnt/β-catenin signaling: components, mechanisms, and diseases. Dev
Cell. 17:9–26. 2009.
|
|
7
|
Paul S and Dey A: Wnt signaling and cancer
development: therapeutic implication. Neoplasma. 55:165–176.
2008.PubMed/NCBI
|
|
8
|
Shinohara A, Yokoyama Y, Wan X, Takahashi
Y, Mori Y, Takami T, et al: Cytoplasmic/nuclear expression without
mutation of exon 3 of the β-catenin gene is frequent in the
development of the neoplasm of the uterine cervix. Gynecol Oncol.
82:450–455. 2001.
|
|
9
|
Ueda M, Gemmill RM, West J, Winn R, Sugita
M, Tanaka N, et al: Mutations of the β- and γ-catenin genes are
uncommon in human lung, breast, kidney, cervical and ovarian
carcinomas. Br J Cancer. 85:64–68. 2001.
|
|
10
|
Chung MT, Sytwu HK, Yan MD, Shih YL, Chang
CC, Yu MH, et al: Promoter methylation of SFRPs gene family in
cervical cancer. Gynecol Oncol. 112:301–306. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lee EJ, Jo M, Rho SB, Park K, Yoo YN, Park
J, et al: Dkk3, downregulated in cervical cancer, functions
as a negative regulator of β-catenin. Int J Cancer. 124:287–297.
2009. View Article : Google Scholar
|
|
12
|
Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi
H, Suga T, Utsugi T, et al: Mutation of the mouse klotho
gene leads to a syndrome resembling ageing. Nature. 390:45–51.
1997. View Article : Google Scholar
|
|
13
|
Imura A, Iwano A, Tohyama O, Tsuji Y,
Nozaki K, Hashimoto N, et al: Secreted Klotho protein in sera and
CSF: implication for post-translational cleavage in release of
Klotho protein from cell membrane. FEBS Lett. 565:143–147. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen CD, Podvin S, Gillespie E, Leeman SE
and Abraham CR: Insulin stimulates the cleavage and release of the
extracellular domain of Klotho by ADAM10 and ADAM17. Proc Natl Acad
Sci USA. 104:19796–19801. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mian IS: Sequence, structural, functional,
and phylogenetic analyses of three glycosidase families. Blood
Cells Mol Dis. 24:83–100. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kurosu H, Ogawa Y, Miyoshi M, Yamamoto M,
Nandi A, Rosenblatt KP, et al: Regulation of fibroblast growth
factor-23 signaling by klotho. J Biol Chem. 281:6120–6123. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tao Y, Pinzi V, Bourhis J and Deutsch E:
Mechanisms of disease: signaling of the insulin-like growth factor
1 receptor pathway - therapeutic perspectives in cancer. Nat Clin
Pract Oncol. 4:591–602. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mattarocci S, Abbruzzese C, Mileo AM,
Visca P, Antoniani B, Alessandrini G, et al: Intracellular presence
of insulin and its phosphorylated receptor in non-small cell lung
cancer. J Cell Physiol. 221:766–770. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lee J, Jeong DJ, Kim J, Lee S, Park JH,
Chang B, et al: The anti-aging gene KLOTHO is a novel target
for epigenetic silencing in human cervical carcinoma. Mol Cancer.
9:1092010.
|
|
20
|
Wolf I, Levanon-Cohen S, Bose S, Ligumsky
H, Sredni B, Kanety H, et al: Klotho: a tumor suppressor and a
modulator of the IGF-1 and FGF pathways in human breast cancer.
Oncogene. 27:7094–7105. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Polyak K and Weinberg RA: Transitions
between epithelial and mesenchymal states: acquisition of malignant
and stem cell traits. Nat Rev Cancer. 9:265–273. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Huber AH and Weis WI: The structure of the
β-catenin/E-cadherin complex and the molecular basis of diverse
ligand recognition by β-catenin. Cell. 105:391–402. 2001.
|
|
23
|
Laux H, Tomer R, Mader MT, Smida J,
Budczies J, Kappler R, et al: Tumor-associated E-cadherin mutations
do not induce Wnt target gene expression, but affect E-cadherin
repressors. Lab Invest. 84:1372–1386. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yang J and Weinberg RA:
Epithelial-mesenchymal transition: at the crossroads of development
and tumor metastasis. Dev Cell. 14:818–829. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Vallin J, Thuret R, Giacomello E, Faraldo
MM, Thiery JP and Broders F: Cloning and characterization of three
Xenopus slug promoters reveal direct regulation by
Lef/β-catenin signaling. J Biol Chem. 276:30350–30358.
2001.PubMed/NCBI
|
|
26
|
Howe LR, Watanabe O, Leonard J and Brown
AM: Twist is up-regulated in response to Wnt1 and inhibits mouse
mammary cell differentiation. Cancer Res. 63:1906–1913.
2003.PubMed/NCBI
|
|
27
|
Marchenko GN, Marchenko ND, Leng J and
Strongin AY: Promoter characterization of the novel human matrix
metalloproteinase-26 gene: regulation by the T-cell factor-4
implies specific expression of the gene in cancer cells of
epithelial origin. Biochem J. 363:253–262. 2002. View Article : Google Scholar
|
|
28
|
Wu B, Crampton SP and Hughes CC: Wnt
signaling induces matrix metalloproteinase expression and regulates
T cell transmigration. Immunity. 26:227–239. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yee DS, Tang Y, Li X, Liu Z, Guo Y,
Ghaffar S, et al: The Wnt inhibitory factor 1 restoration in
prostate cancer cells was associated with reduced tumor growth,
decreased capacity of cell migration and invasion and a reversal of
epithelial to mesenchymal transition. Mol Cancer. 9:1622010.
View Article : Google Scholar
|
|
30
|
Wang H, Mannava S, Grachtchouk V, Zhuang
D, Soengas MS, Gudkov AV, et al: c-Myc depletion inhibits
proliferation of human tumor cells at various stages of the cell
cycle. Oncogene. 27:1905–1915. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Fu M, Wang C, Li Z, Sakamaki T and Pestell
RG: Minireview: Cyclin D1: normal and abnormal functions.
Endocrinology. 145:5439–5447. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kainz C, Kohlberger P, Tempfer C, Sliutz
G, Gitsch G, Reinthaller A, et al: Prognostic value of CD44 splice
variants in human stage III cervical cancer. Eur J Cancer.
31A:1706–1709. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang L, Wang X, Jie P, Lu H, Zhang S, Lin
X, et al: Klotho is silenced through promoter hypermethylation in
gastric cancer. Am J Cancer Res. 1:111–119. 2011.PubMed/NCBI
|
|
34
|
King GD, Rosene DL and Abraham CR:
Promoter methylation and age-related downregulation of Klotho in
rhesus monkey. Age (Dordr). Sep 16–2011.(Epub ahead of print).
|
|
35
|
Pan J, Zhong J, Gan LH, Chen SJ, Jin HC,
Wang X, et al: Klotho, an anti-senescence related gene, is
frequently inactivated through promoter hypermethylation in
colorectal cancer. Tumour Biol. 32:729–735. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Liu H, Fergusson MM, Castilho RM, Liu J,
Cao L, Chen J, et al: Augmented Wnt signaling in a mammalian model
of accelerated aging. Science. 317:803–806. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kang Y and Massague J:
Epithelial-mesenchymal transitions: twist in development and
metastasis. Cell. 118:277–279. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Doi S, Zou Y, Togao O, Pastor JV, John GB,
Wang L, et al: Klotho inhibits transforming growth factor-beta1
(TGF-beta1) signaling and suppresses renal fibrosis and cancer
metastasis in mice. J Biol Chem. 286:8655–8665. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Branca M, Giorgi C, Ciotti M, Santini D,
Di Bonito L, Costa S, et al: Down-regulation of E-cadherin is
closely associated with progression of cervical intraepithelial
neoplasia (CIN), but not with high-risk human papillomavirus (HPV)
or disease outcome in cervical cancer. Eur J Gynaecol Oncol.
27:215–223. 2006.
|
|
40
|
Camilli TC, Xu M, O’Connell MP, Chien B,
Frank BP, Subaran S, et al: Loss of Klotho during melanoma
progression leads to increased filamin cleavage, increased Wnt5A
expression, and enhanced melanoma cell motility. Pigment Cell
Melanoma Res. 24:175–186. 2011. View Article : Google Scholar : PubMed/NCBI
|
